Quadrant Capital Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-107
Closed -$4K 2132
2016
Q2
$4K Hold
107
﹤0.01% 1306
2016
Q1
$7K Buy
+107
New +$7K ﹤0.01% 1095